HROW - Harrow Health, Inc.
NEXT EARNINGS:
Mar 26, 2026
(in 29 days)
EPS Est: $0.40
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$76.00
DETAILS
HIGH:
$94.00
LOW:
$64.00
MEDIAN:
$70.00
CONSENSUS:
$76.00
UPSIDE:
43.99%
Market Cap:
1.95B
Volume:
456,470
Avg Volume:
538,941
52 Week Range:
20.85-54.85
Sector:
Healthcare
Industry:
Drug Manufacturers - Specialty & Generic
Beta:
0.10
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
382
IPO Date:
2007-09-28
EPS (TTM):
-0.49
P/E Ratio:
-68.42
Revenue (TTM):
199.61M
Total Assets:
388.97M
Total Debt:
228.83M
Cash & Equiv:
47.25M
Rev Growth (5Y):
31.3%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
3.0%
Debt/Equity:
3.29
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-11-10 | $0.33 | $0.22 | +50.0% | $71.6M | $88.0M | -18.6% |
| 2025-08-11 | $0.24 | $0.31 | -23.4% | $63.7M | $73.9M | -13.8% |
| 2025-05-08 | $-0.38 | $0.02 | -2000.0% | $47.8M | $67.9M | -29.5% |
| 2025-03-27 | $0.25 | $0.11 | +127.3% | $66.8M | $58.4M | +14.4% |
| 2024-11-13 | $-0.12 | $-0.05 | -140.0% | $49.3M | $59.1M | -16.6% |
| 2024-08-07 | $-0.13 | $-0.25 | +48.0% | $48.9M | $49.1M | -0.2% |
| 2024-05-13 | $-0.28 | $-0.25 | -12.0% | $34.6M | $37.3M | -7.2% |
| 2024-03-19 | $-0.27 | $-0.05 | -455.6% | $36.4M | $37.9M | -4.0% |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 199.61M | 130.19M | 88.59M | 72.48M | 48.87M | 51.16M | 41.37M | 26.77M | 19.94M | 9.72M | 1.66M | 10,000 |
| Net Income | (17.48M) | (24.41M) | (14.09M) | (18.01M) | (3.36M) | 168,000 | 14.62M | (11.98M) | (19.09M) | (15.90M) | (10.12M) | (7.64M) |
| EPS | -0.49 | -0.75 | -0.51 | -0.69 | -0.13 | 0.01 | 0.67 | -0.60 | -1.50 | -1.66 | -1.11 | -0.88 |
| Total Assets | 388.97M | 311.75M | 157.38M | 98.33M | 57.47M | 59.09M | 49.45M | 23.92M | 27.25M | 14.13M | 10.24M | 15.76M |
| Total Debt | 228.83M | 190.50M | 112.23M | 77.96M | 23.53M | 20.99M | 15.25M | 15.33M | 13.69M | 8.36M | 43,080 | 0 |
| Cash & Equivalents | 47.25M | 74.08M | 96.27M | 42.17M | 4.10M | 4.75M | 6.64M | 4.02M | 8.85M | 2.69M | 8.21M | 15.58M |
| Operating Cash Flow | (22.20M) | 3.84M | 1.71M | 5.08M | (1.10M) | 950,000 | 687,000 | (8.80M) | (11.21M) | (11.14M) | (7.06M) | (4.44M) |
| Free Cash Flow | (60.88M) | (148.71M) | (6.07M) | (23.43M) | (2.09M) | (887,000) | (1.52M) | (9.88M) | (18.35M) | (12.32M) | (7.23M) | (4.46M) |
| FCF per Share | -1.71 | -4.56 | -0.22 | -0.88 | -0.08 | -0.04 | -0.07 | -0.49 | -1.44 | -1.29 | -0.79 | -0.52 |
| Book Value | 69.65M | 70.36M | 27.59M | 11.29M | 27.18M | 27.71M | 24.75M | 2.62M | 6.43M | (1.39M) | 8.15M | 15.11M |
| Cash & ST Investments | 47.25M | 82.77M | 101.86M | 50.67M | 32.75M | 29.95M | 28.06M | 4.02M | 8.85M | 2.69M | 8.21M | 15.58M |
| ROC Equity | -0.25 | -0.35 | -0.51 | -1.60 | -0.12 | 0.01 | 0.59 | -4.58 | -2.97 | N/A | -1.24 | -0.51 |